🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of this study are to evaluate the antiviral efficacy...
Status
Completed
Location
Multiple Locations
Start Date
2015-06-17
Trial ID
NCT02472886
Background: \- GS-7977, GS-5885, GS-9669, and GS-9451 are new drugs for tr...
Status
Completed
Location
Unity Health Care, Inc./DC General
Start Date
2013-01
Trial ID
NCT01805882
Treatments Being Tested
This study will evaluate the antiviral efficacy, safety, and tolerability o...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02413593
The purpose of this study is to assess the ability of eltrombopag to mainta...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10
Trial ID
NCT00529568
Treatments Being Tested
The purposes of the PLUS study were to confirm the safety and tolerability ...
Status
Completed
Location
Henry Ford Hospital
Start Date
2008-01
Trial ID
NCT00593151
Treatments Being Tested
The study hypothesis is to determine the feasibility of switching HIV-HCV c...
Status
Unknown
Location
Saskatchewan Health Authority
Start Date
2018-02-01
Trial ID
NCT03549312
Patients with transfusion dependent Beta Thalassemia suffer from a high inc...
Status
Completed
Location
Pediatric Hematology Unit, Faculty of Medicine, Tanta University
Start Date
2017-10-01
Trial ID
NCT03961828
Treatments Being Tested
Parts A and B of this study are designed to evaluate the safety, tolerabili...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01852604
The primary purpose of this study is to evaluate the safety, tolerability, ...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01193478
The purpose of this study was to evaluate the safety, tolerability, and eff...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01700179
Treatments Being Tested